English
简体中文
Total: £ 56.28
Published Date: 2026-03-20 | Pages: 110 | Tables: 114 | Medical Devices & Consumables
The global Membranes for Pharmaceuticals and Biotechnology market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Membranes for Pharmaceuticals and Biotechnology competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Membranes for pharmaceuticals and biotechnology play a crucial role in the purification, separation, and concentration of biomolecules and pharmaceutical compounds. These membranes, often made from advanced polymeric materials, provide high selectivity and efficiency, essential for processes such as drug formulation, protein purification, and cell culture. They enable the removal of impurities and contaminants while preserving the integrity and functionality of the target molecules. With continuous advancements in membrane technology, including improvements in material science and manufacturing techniques, their application in pharmaceuticals and biotechnology is expanding, driving innovation and enhancing the quality and safety of biopharmaceutical products.
The North American market for Membranes for Pharmaceuticals and Biotechnology is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Membranes for Pharmaceuticals and Biotechnology is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Membranes for Pharmaceuticals and Biotechnology include Danaher, Sartorius, 3M, Merck, Asahi Kasei, Hangzhou Cobetter, Repligen, Parker, Kovalus Separation Solutions, Jiangsu Solicitude Medical Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Membranes for Pharmaceuticals and Biotechnology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Membranes for Pharmaceuticals and Biotechnology. The Membranes for Pharmaceuticals and Biotechnology market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Membranes for Pharmaceuticals and Biotechnology market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Membranes for Pharmaceuticals and Biotechnology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Danaher
Sartorius
3M
Merck
Asahi Kasei
Hangzhou Cobetter
Repligen
Parker
Kovalus Separation Solutions
Jiangsu Solicitude Medical Technology
Segment by Type
PSU and PESU
PVDF
PTFE
PP
Other
by Application
Pharmaceuticals
Biotechnology
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Membranes for Pharmaceuticals and Biotechnology manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Membranes for Pharmaceuticals and Biotechnology sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Membranes for Pharmaceuticals and Biotechnology Market Overview
1.1 Product Definition
1.2 Membranes for Pharmaceuticals and Biotechnology by Type
1.2.1 Global Membranes for Pharmaceuticals and Biotechnology Market Value by Type: 2025 vs 2032
1.2.2 PSU and PESU
1.2.3 PVDF
1.2.4 PTFE
1.2.5 PP
1.2.6 Other
1.3 Membranes for Pharmaceuticals and Biotechnology by Application
1.3.1 Global Membranes for Pharmaceuticals and Biotechnology Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Biotechnology
1.4 Global Membranes for Pharmaceuticals and Biotechnology Market Size Estimates and Forecasts
1.4.1 Global Membranes for Pharmaceuticals and Biotechnology Revenue 2021–2032
1.4.2 Global Membranes for Pharmaceuticals and Biotechnology Sales 2021–2032
1.4.3 Global Membranes for Pharmaceuticals and Biotechnology Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Membranes for Pharmaceuticals and Biotechnology Market Competition by Manufacturers
2.1 Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Manufacturers (2021–2026)
2.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Membranes for Pharmaceuticals and Biotechnology Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Membranes for Pharmaceuticals and Biotechnology, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Product Types and Applications
2.7 Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Date of Entry into the Industry
2.8 Global Membranes for Pharmaceuticals and Biotechnology Market Competitive Situation and Trends
2.8.1 Global Membranes for Pharmaceuticals and Biotechnology Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Membranes for Pharmaceuticals and Biotechnology Players Market Share by Revenue
2.8.3 Global Membranes for Pharmaceuticals and Biotechnology Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Membranes for Pharmaceuticals and Biotechnology Market Scenario by Region
3.1 Global Membranes for Pharmaceuticals and Biotechnology Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Membranes for Pharmaceuticals and Biotechnology Sales by Region: 2021–2032
3.2.1 Global Membranes for Pharmaceuticals and Biotechnology Sales by Region: 2021–2026
3.2.2 Global Membranes for Pharmaceuticals and Biotechnology Sales by Region: 2027–2032
3.3 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Region: 2021–2032
3.3.1 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Region: 2021–2026
3.3.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Region: 2027–2032
3.4 North America Membranes for Pharmaceuticals and Biotechnology Market Facts & Figures by Country
3.4.1 North America Membranes for Pharmaceuticals and Biotechnology Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Membranes for Pharmaceuticals and Biotechnology Sales by Country (2021–2032)
3.4.3 North America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Membranes for Pharmaceuticals and Biotechnology Market Facts & Figures by Country
3.5.1 Europe Membranes for Pharmaceuticals and Biotechnology Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Membranes for Pharmaceuticals and Biotechnology Sales by Country (2021–2032)
3.5.3 Europe Membranes for Pharmaceuticals and Biotechnology Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Membranes for Pharmaceuticals and Biotechnology Market Facts & Figures by Region
3.6.1 Asia Pacific Membranes for Pharmaceuticals and Biotechnology Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Membranes for Pharmaceuticals and Biotechnology Sales by Region (2021–2032)
3.6.3 Asia Pacific Membranes for Pharmaceuticals and Biotechnology Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Membranes for Pharmaceuticals and Biotechnology Market Facts & Figures by Country
3.7.1 Latin America Membranes for Pharmaceuticals and Biotechnology Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Membranes for Pharmaceuticals and Biotechnology Sales by Country (2021–2032)
3.7.3 Latin America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Market Facts & Figures by Country
3.8.1 Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Sales by Country (2021–2032)
3.8.3 Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Membranes for Pharmaceuticals and Biotechnology Sales by Type (2021–2032)
4.1.1 Global Membranes for Pharmaceuticals and Biotechnology Sales by Type (2021–2026)
4.1.2 Global Membranes for Pharmaceuticals and Biotechnology Sales by Type (2027–2032)
4.1.3 Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Type (2021–2032)
4.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Type (2021–2032)
4.2.1 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Type (2021–2026)
4.2.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Type (2027–2032)
4.2.3 Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Type (2021–2032)
4.3 Global Membranes for Pharmaceuticals and Biotechnology Price by Type (2021–2032)
5 Segment by Application
5.1 Global Membranes for Pharmaceuticals and Biotechnology Sales by Application (2021–2032)
5.1.1 Global Membranes for Pharmaceuticals and Biotechnology Sales by Application (2021–2026)
5.1.2 Global Membranes for Pharmaceuticals and Biotechnology Sales by Application (2027–2032)
5.1.3 Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Application (2021–2032)
5.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Application (2021–2032)
5.2.1 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Application (2021–2026)
5.2.2 Global Membranes for Pharmaceuticals and Biotechnology Revenue by Application (2027–2032)
5.2.3 Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Application (2021–2032)
5.3 Global Membranes for Pharmaceuticals and Biotechnology Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Danaher
6.1.1 Danaher Company Information
6.1.2 Danaher Description and Business Overview
6.1.3 Danaher Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Danaher Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.1.5 Danaher Recent Developments/Updates
6.2 Sartorius
6.2.1 Sartorius Company Information
6.2.2 Sartorius Description and Business Overview
6.2.3 Sartorius Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Sartorius Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.2.5 Sartorius Recent Developments/Updates
6.3 3M
6.3.1 3M Company Information
6.3.2 3M Description and Business Overview
6.3.3 3M Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 3M Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.3.5 3M Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Asahi Kasei
6.5.1 Asahi Kasei Company Information
6.5.2 Asahi Kasei Description and Business Overview
6.5.3 Asahi Kasei Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Asahi Kasei Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.5.5 Asahi Kasei Recent Developments/Updates
6.6 Hangzhou Cobetter
6.6.1 Hangzhou Cobetter Company Information
6.6.2 Hangzhou Cobetter Description and Business Overview
6.6.3 Hangzhou Cobetter Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hangzhou Cobetter Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.6.5 Hangzhou Cobetter Recent Developments/Updates
6.7 Repligen
6.7.1 Repligen Company Information
6.7.2 Repligen Description and Business Overview
6.7.3 Repligen Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Repligen Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.7.5 Repligen Recent Developments/Updates
6.8 Parker
6.8.1 Parker Company Information
6.8.2 Parker Description and Business Overview
6.8.3 Parker Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Parker Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.8.5 Parker Recent Developments/Updates
6.9 Kovalus Separation Solutions
6.9.1 Kovalus Separation Solutions Company Information
6.9.2 Kovalus Separation Solutions Description and Business Overview
6.9.3 Kovalus Separation Solutions Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kovalus Separation Solutions Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.9.5 Kovalus Separation Solutions Recent Developments/Updates
6.10 Jiangsu Solicitude Medical Technology
6.10.1 Jiangsu Solicitude Medical Technology Company Information
6.10.2 Jiangsu Solicitude Medical Technology Description and Business Overview
6.10.3 Jiangsu Solicitude Medical Technology Membranes for Pharmaceuticals and Biotechnology Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jiangsu Solicitude Medical Technology Membranes for Pharmaceuticals and Biotechnology Product Portfolio
6.10.5 Jiangsu Solicitude Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Membranes for Pharmaceuticals and Biotechnology Industry Chain Analysis
7.2 Membranes for Pharmaceuticals and Biotechnology Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Membranes for Pharmaceuticals and Biotechnology Production Mode & Process Analysis
7.4 Membranes for Pharmaceuticals and Biotechnology Sales and Marketing
7.4.1 Membranes for Pharmaceuticals and Biotechnology Sales Channels
7.4.2 Membranes for Pharmaceuticals and Biotechnology Distributors
7.5 Membranes for Pharmaceuticals and Biotechnology Customer Analysis
8 Membranes for Pharmaceuticals and Biotechnology Market Dynamics
8.1 Membranes for Pharmaceuticals and Biotechnology Industry Trends
8.2 Membranes for Pharmaceuticals and Biotechnology Market Drivers
8.3 Membranes for Pharmaceuticals and Biotechnology Market Challenges
8.4 Membranes for Pharmaceuticals and Biotechnology Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Membranes for Pharmaceuticals and Biotechnology Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Membranes for Pharmaceuticals and Biotechnology Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Membranes for Pharmaceuticals and Biotechnology Market Competitive Situation by Manufacturers in 2025
Table 4. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Membranes for Pharmaceuticals and Biotechnology Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Membranes for Pharmaceuticals and Biotechnology Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Membranes for Pharmaceuticals and Biotechnology Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Membranes for Pharmaceuticals and Biotechnology, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Product Types and Applications
Table 12. Global Key Manufacturers of Membranes for Pharmaceuticals and Biotechnology, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Membranes for Pharmaceuticals and Biotechnology Companies by Tier (Tier 1, Tier 2, Tier 3), based on Membranes for Pharmaceuticals and Biotechnology Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Membranes for Pharmaceuticals and Biotechnology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Membranes for Pharmaceuticals and Biotechnology Sales by Region (K Units), 2021–2026
Table 18. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Region (2021–2026)
Table 19. Global Membranes for Pharmaceuticals and Biotechnology Sales by Region (K Units), 2027–2032
Table 20. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Region (2027–2032)
Table 21. Global Membranes for Pharmaceuticals and Biotechnology Revenue by Region (US$ Million), 2021–2026
Table 22. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Region (2021–2026)
Table 23. Global Membranes for Pharmaceuticals and Biotechnology Revenue by Region (US$ Million), 2027–2032
Table 24. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Region (2027–2032)
Table 25. North America Membranes for Pharmaceuticals and Biotechnology Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2021–2026
Table 27. North America Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2027–2032
Table 28. North America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2021–2026
Table 29. North America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Membranes for Pharmaceuticals and Biotechnology Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2021–2026
Table 32. Europe Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2027–2032
Table 33. Europe Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Membranes for Pharmaceuticals and Biotechnology Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2021–2026
Table 42. Latin America Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2027–2032
Table 43. Latin America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Revenue by Country (US$ Million), 2027–2032
Table 50. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units) by Type (2021–2026)
Table 51. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units) by Type (2027–2032)
Table 52. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Type (2021–2026)
Table 53. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Type (2027–2032)
Table 54. Global Membranes for Pharmaceuticals and Biotechnology Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Membranes for Pharmaceuticals and Biotechnology Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Type (2021–2026)
Table 57. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Type (2027–2032)
Table 58. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Type (2021–2026)
Table 59. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Type (2027–2032)
Table 60. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units) by Application (2021–2026)
Table 61. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units) by Application (2027–2032)
Table 62. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Application (2021–2026)
Table 63. Global Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Application (2027–2032)
Table 64. Global Membranes for Pharmaceuticals and Biotechnology Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Membranes for Pharmaceuticals and Biotechnology Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Application (2021–2026)
Table 67. Global Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Application (2027–2032)
Table 68. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Application (2021–2026)
Table 69. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Application (2027–2032)
Table 70. Danaher Company Information
Table 71. Danaher Description and Business Overview
Table 72. Danaher Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Danaher Membranes for Pharmaceuticals and Biotechnology Product
Table 74. Danaher Recent Developments/Updates
Table 75. Sartorius Company Information
Table 76. Sartorius Description and Business Overview
Table 77. Sartorius Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sartorius Membranes for Pharmaceuticals and Biotechnology Product
Table 79. Sartorius Recent Developments/Updates
Table 80. 3M Company Information
Table 81. 3M Description and Business Overview
Table 82. 3M Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. 3M Membranes for Pharmaceuticals and Biotechnology Product
Table 84. 3M Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck Membranes for Pharmaceuticals and Biotechnology Product
Table 89. Merck Recent Developments/Updates
Table 90. Asahi Kasei Company Information
Table 91. Asahi Kasei Description and Business Overview
Table 92. Asahi Kasei Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Asahi Kasei Membranes for Pharmaceuticals and Biotechnology Product
Table 94. Asahi Kasei Recent Developments/Updates
Table 95. Hangzhou Cobetter Company Information
Table 96. Hangzhou Cobetter Description and Business Overview
Table 97. Hangzhou Cobetter Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hangzhou Cobetter Membranes for Pharmaceuticals and Biotechnology Product
Table 99. Hangzhou Cobetter Recent Developments/Updates
Table 100. Repligen Company Information
Table 101. Repligen Description and Business Overview
Table 102. Repligen Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Repligen Membranes for Pharmaceuticals and Biotechnology Product
Table 104. Repligen Recent Developments/Updates
Table 105. Parker Company Information
Table 106. Parker Description and Business Overview
Table 107. Parker Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Parker Membranes for Pharmaceuticals and Biotechnology Product
Table 109. Parker Recent Developments/Updates
Table 110. Kovalus Separation Solutions Company Information
Table 111. Kovalus Separation Solutions Description and Business Overview
Table 112. Kovalus Separation Solutions Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kovalus Separation Solutions Membranes for Pharmaceuticals and Biotechnology Product
Table 114. Kovalus Separation Solutions Recent Developments/Updates
Table 115. Jiangsu Solicitude Medical Technology Company Information
Table 116. Jiangsu Solicitude Medical Technology Description and Business Overview
Table 117. Jiangsu Solicitude Medical Technology Membranes for Pharmaceuticals and Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Jiangsu Solicitude Medical Technology Membranes for Pharmaceuticals and Biotechnology Product
Table 119. Jiangsu Solicitude Medical Technology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Membranes for Pharmaceuticals and Biotechnology Distributors List
Table 123. Membranes for Pharmaceuticals and Biotechnology Customers List
Table 124. Membranes for Pharmaceuticals and Biotechnology Market Trends
Table 125. Membranes for Pharmaceuticals and Biotechnology Market Drivers
Table 126. Membranes for Pharmaceuticals and Biotechnology Market Challenges
Table 127. Membranes for Pharmaceuticals and Biotechnology Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Membranes for Pharmaceuticals and Biotechnology
Figure 2. Global Membranes for Pharmaceuticals and Biotechnology Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Membranes for Pharmaceuticals and Biotechnology Market Share by Type: 2025 & 2032
Figure 4. PSU and PESU Product Picture
Figure 5. PVDF Product Picture
Figure 6. PTFE Product Picture
Figure 7. PP Product Picture
Figure 8. Other Product Picture
Figure 9. Global Membranes for Pharmaceuticals and Biotechnology Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Membranes for Pharmaceuticals and Biotechnology Market Share by Application: 2025 & 2032
Figure 11. Pharmaceuticals
Figure 12. Biotechnology
Figure 13. Global Membranes for Pharmaceuticals and Biotechnology Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Membranes for Pharmaceuticals and Biotechnology Market Size (US$ Million), 2021–2032
Figure 15. Global Membranes for Pharmaceuticals and Biotechnology Sales (K Units), 2021–2032
Figure 16. Global Membranes for Pharmaceuticals and Biotechnology Average Price (US$/Unit), 2021–2032
Figure 17. Membranes for Pharmaceuticals and Biotechnology Report Years Considered
Figure 18. Membranes for Pharmaceuticals and Biotechnology Sales Share by Manufacturers in 2025
Figure 19. Global Membranes for Pharmaceuticals and Biotechnology Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Membranes for Pharmaceuticals and Biotechnology Players: Market Share by Revenue in Membranes for Pharmaceuticals and Biotechnology in 2025
Figure 21. Membranes for Pharmaceuticals and Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Membranes for Pharmaceuticals and Biotechnology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Country (2021–2032)
Figure 24. North America Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Country (2021–2032)
Figure 25. United States Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Country (2021–2032)
Figure 28. Europe Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Country (2021–2032)
Figure 29. Germany Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Region (2021–2032)
Figure 36. China Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Country (2021–2032)
Figure 44. Latin America Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Membranes for Pharmaceuticals and Biotechnology Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Membranes for Pharmaceuticals and Biotechnology Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Membranes for Pharmaceuticals and Biotechnology by Type (2021–2032)
Figure 55. Global Revenue Market Share of Membranes for Pharmaceuticals and Biotechnology by Type (2021–2032)
Figure 56. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Membranes for Pharmaceuticals and Biotechnology by Application (2021–2032)
Figure 58. Global Revenue Market Share of Membranes for Pharmaceuticals and Biotechnology by Application (2021–2032)
Figure 59. Global Membranes for Pharmaceuticals and Biotechnology Price (US$/Unit) by Application (2021–2032)
Figure 60. Membranes for Pharmaceuticals and Biotechnology Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
